APA (7th ed.) Citation

Gracia-Cazaña T, Bernal-Masferrer L, Morales-Callaghan AM, Almenara-Blasco M, & Gilaberte Y. (2023). Risankizumab for the Treatment of Moderate to Severe Psoriasis: Impact on Health-Related Quality of Life and Psychological Wellbeing. Dove Medical Press.

Chicago Style (17th ed.) Citation

Gracia-Cazaña T, Bernal-Masferrer L, Morales-Callaghan AM, Almenara-Blasco M, and Gilaberte Y. Risankizumab for the Treatment of Moderate to Severe Psoriasis: Impact on Health-Related Quality of Life and Psychological Wellbeing. Dove Medical Press, 2023.

MLA (9th ed.) Citation

Gracia-Cazaña T, et al. Risankizumab for the Treatment of Moderate to Severe Psoriasis: Impact on Health-Related Quality of Life and Psychological Wellbeing. Dove Medical Press, 2023.